Curriculum Vitae Michalis (Michael) V. Karamouzis - MyLoyalCard

ladder cancer in the molecular era: current status and future promise”, Expert
Opin Investig Drugs, 19: 875-87, 2010.
79) A. Kotsinas, I.S. Pateras, P.S. Galanos, M.V. Karamouzis, P.P. Sfikakis, V.G.
Gorgoulis: “Why is p53-inducible gene 3 rarely affected in cancer?”, Oncogene,
29: 5220, 2010.
80) E.G. Iliopoulou, P. Kountourakis, M.V. Karamouzis, D. Doufexis, A. Ardavanis,
C.N. Baxevanis, G. Rigatos,M. Papamichail, S.A. Perez: “A phase I trial of
adoptive transfer of allogeneic natural killer cells in patients with advanced non-
small cell lung cancer”, Cancer Immunol Immunother, 59: 1781-89, 2010.
81) A.G. Pallis, M.V. Karamouzis: “DNA repair pathways and their implication in
cancer treatment”, Cancer Metastasis Rev, 29: 677-85, 2010.
82) Argiris, M.V. Karamouzis, W.E. Gooding, B.F. Branstetter, S. Zhong, L.E. Raez,
P. Savvides, M. Romkes: “Phase II trial of pemetrexed and bevacizumab in
patients with recurrent or metastatic head and neck cancer”, J Clin Oncol, 29:
1140-45. 2011.
83) Argiris, M.V. Karamouzis: “Empowering induction therapy for locally advanced
head and neck cancer”, Ann Oncol, 22: 773-781, 2011.
84) Argiris, M.V. Karamouzis, R. Smith, A. Kotsakis, M.K. Gibson, S.Y. La, S. Kim,
B.F. Branstetter, Y. Shuai, M. Romkes, L. Wang, J.R. Grandis, R.L. Ferris, J.T.
Johnson & D.E. Heron: “Phase I trial of pemetrexed in combination with
cetuximab and concurrent radiotherapy in patients with head and neck cancer”,
Ann Oncol, 22: 2482-2488, 2011.
85) M.V. Karamouzis & A.G. Papavassiliou: “Transcription Factor Networks as
Targets for Therapeutic Intervention of Cancer - The Breast Cancer Paradigm”,
Mol Med 2011.
86) M.V. Karamouzis & A.G. Papavassiliou: “Targeting insulin-like growth factor in
breast cancer therapeutics”, Crit Rev Oncol Hematol, 2012, in press.
Abstracts in international congresses
1) M.V. Karamouzis, et al.: “Circulating Regulatory T Cells in Advanced Breast
Cancer Patients”, 42 th ASCO Annual Meeting, Atlanda, Giorgia, U.S.A., June 2-6,
2006.
10
10